David R. Keenan, President / CEO of Nanoscience Technologies, Inc. Conducts CEOcast Interview
The interview centered on the nanotechnology arena and identified the various stages of development. Mr. Keenan identified the focus of Nanoscience Technologies, Inc. (NTI) explaining the effort is centered on the licensed properties of Dr. Nadrian Seeman's NYU laboratory and his development efforts to create processes and tools for a wide range of manufacturing environments. Mr. Keenan summarized the effort very succinctly by stating, "What Dr. Seeman has developed is a structural DNA approach to nanotechnology where he uses short engineered strands of DNA to organize nanoparticles with very high precision". He went on to state that the technology being developed by Dr. Seeman's lab will have to be integrated by large corporations now who are targeting to reap the benefits of the high value proposition of nanotechnology in their product lines at the turn of the decade. He stated it was the larger corporations with the vision of the future that would become the collaborative partners for the Company in the months ahead.
“What Dr. Seeman has developed is a structural DNA approach to nanotechnology where he uses short engineered strands of DNA to organize nanoparticles with very high precision”
For a complete transcript of this release please go to the Nanoscience Technologies, Inc. company website at: http://www.nanoscience-tech.com.